Scientific foundation explains efficacy of Excede® for Swine against SRD pathogens
Jul 14, 2021Jennifer Grullon
DISCOVERIES, Issue 22: A robust body of research explains the efficacy of Excede® for Swine (ceftiofur crystalline free acid) against four of the bacterial pathogens associated with swine...
Pigs with APP have less mortality, fewer lung lesions after treatment with Excede® for Swine compared to enrofloxacin
Dec 15, 2020Jennifer Grullon
DISCOVERIES, Issue 20: Pigs with swine respiratory disease due to Actinobacillus pleuropneumoniae were treated with Excede® for Swine (ceftiofur crystallinefree acid) or enrofloxacin in a...
Fostera® PRRS protects against diverse PRRS virus field strains
Oct 28, 2020Jennifer Grullon
DISCOVERIES, Issue 19: PRRS has been described as one of the most important swine diseases of the last half-century. An estimated 20% to 25% of herds are still affected, and the syndrome remains the...
Vaccine trial data versus lineage: What’s the best way to predict PRRS vaccine performance?
Jun 24, 2020Jennifer Grullon
TOOLBOX, Issue 20: An interview with Eva Jablonski, DVM, PRRS Specialist, Senior Technical Services Veterinarian, Zoetis
